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Thirty  years  ago,  it was  discovered  that  14-3-3  proteins  could  activate  enzymes  involved  in  amino  acid
metabolism.  In the  following  decades,  14-3-3s  have  been  shown  to be involved  in  many  different  signaling
pathways  that modulate  cellular  and  whole  body  energy  and  nutrient  homeostasis.  Large  scale  screening
for  cellular  binding  partners  of  14-3-3  has  identiﬁed  numerous  proteins  that participate  in  regulation  of
metabolic  pathways,  although  only  a  minority  of these  targets  have  yet  been  subject  to  detailed  studies.
Because  of the  wide  distribution  of  potential  14-3-3  targets  and  the  resurging  interest  in metabolic
pathway  control  in  diseases  like cancer,  diabetes,  obesity  and  cardiovascular  disease,  we review  theell  signaling role  of  14-3-3  proteins  in  the regulation  of core  and  specialized  cellular  metabolic  functions.  We  cite
illustrative  examples  of  14-3-3  action  through  their  direct  modulation  of  individual  enzymes  and  through
regulation  of  master  switches  in cellular  pathways,  such  as  insulin  signaling,  mTOR-  and  AMP  dependent
kinase  signaling  pathways,  as  well  as  regulation  of autophagy.  We  further  illustrate  the  quantitative
impact  of  14-3-3  association  on  signal  response  at the  target  protein  level  and  we discuss  implications
of  recent  ﬁndings  showing  14-3-3  protein  membrane  binding  of  target  proteins.© 2011 Elsevier Ltd. 
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. Introduction
In unicellular as well as multicellular organisms, metabolism
eeds to be tightly regulated according to demand of cellu-
ar processes such as cell growth, proliferation, heat production
nd mechanical transformations, e.g. muscle cell contraction and
igration. At the organism level, different tissues are formed
o cope with specialized functions ensuring optimal energy con-
ervation and nutrient availability for life and reproduction. Key
ignaling pathways elicit the co-regulation of metabolism at the
ellular and tissue level and during the past decades, evidence
as accumulated about the involvement of 14-3-3 proteins in
his regulation. The 14-3-3 proteins are being implicated in a
rowing number of cell biology processes, attesting to the multi-
unctionality of this ubiquitous eukaryotic adaptor protein family.
ere we review examples of 14-3-3 involvement in some metabolic
rocesses, emphasizing their regulatory roles in energy metabolism
nd biosynthetic reaction pathways.
Afﬁnity puriﬁcation of cellular 14-3-3 binding proteins in pro-
eomic studies provide evidence for several hundred different
inding partners (possibly >500) associated with most cellular pro-
esses [1–8]. Although the associations with many of these binding
artners have not been completely veriﬁed yet, these proteomic
nd interactomic studies clearly illustrate the diverse biologi-
al functions associated with this protein family. The extensive
nteractome of the 14-3-3 proteins and its regulation by pro-
ein phosphorylation events suggest a fundamental function of
hese proteins in signaling related to cellular metabolic states. The
rchetypical peptide sequence requirements for binding to 14-3-
 have been known for a long time [9] and have recently been
eviewed [10], though structural features outside the binding motif
an also contribute [11].
The 14-3-3 proteins seem to be expressed in all eukaryotic cell
ypes and are highly abundant in the mammalian nervous system
12]. Among the seven mammalian 14-3-3 isoforms (/, , , ,
/, 	/
, ) there are reported differences in the isoform expres-
ion pattern between cell-types, tissues and various laboratory cell
ines [13,14]. The underlying regulatory mechanisms responsible
or controlling the cellular levels of different 14-3-3 isoforms are
till poorly understood. Still, evidence points to a rich and dynamic
egulation of 14-3-3 expression, exempliﬁed by epigenetic regula-
ion of 14-3-3 in cancer [15], transcriptional regulation [16–18],
nd regulation by micro-RNA [19,20].
The two 14-3-3 isoforms in yeast seem to provide overlapping
unctionality as suggested by viable single versus lethal double
nockout. Similar gross redundancy is likely to exist for the mam-
alian 14-3-3 proteins, but with more genetically modiﬁed models
ecoming available and the use of reﬁned whole animal analy-
is, one will expect more isoform-speciﬁc functions to emerge.
hus, disruption of the 14-3-3 isoform (YWHAE gene product)
as led to its functional association with brain development and
euronal migration and it is found deleted in individuals with
iller–Dieker syndrome [21]. It has been reported that a YWHAE
olymorphism is associated with schizophrenia [22], however, in
ther samples this association has not been replicated [23]. Further-
ore, 14-3-3 (YWHAH gene product) has been associated with
sychotic bipolar disorder [24,25]. Less functional specialization
eems to be associated with 14-3-3 based on its disruption in
ouse [26], yet a link to brain and heart development has been
ound by similar studies in zebraﬁsh [27]. The 14-3-3 isoform
as been mainly associated with regulation of cell proliferation
nd appears to be the most specialized of the mammalian iso-
orms, which may  explain why it preferentially forms homodimers.
his brings up a second unresolved issue of 14-3-3 function –
omodimers versus heterodimers, and the severe effects of 14-3-3
isruption might be related to its ability to form heterodimers withpmental Biology 22 (2011) 713– 719
most  of the other isoforms [28–30]. Interestingly, some cellular
functions have been associated with speciﬁc 14-3-3 heterodimers
such as aldosterone stimulated sodium channel translocation (14-
3-3/) and keratinocyte migration by the more unusual 14-3-3
/
[28,31].
The main focus of 14-3-3 biology in mammalian systems has
been on their modulation of cellular signaling pathways, cell death,
cell-cycle and cytoskeletal dynamics. However, the ﬁrst functional
targets for 14-3-3 proteins were enzymes of specialized amino acid
metabolism, i.e. tyrosine- and tryptophan hydroxylase [32] (TH and
TPH, respectively), giving rise to their name tyrosine- and trypto-
phan hydroxylase activators (YWHAs) and putting them in a central
position as modulators of catecholamine and serotonin biosyn-
thesis. In plants, 14-3-3 function has been mainly associated with
metabolic regulation (reviewed in [33]), though several examples
of targets in signal transduction have been reported and cell sig-
naling is an increasingly established function of 14-3-3s in plants
[33–35].
2. Direct modulation of metabolic enzyme function by
14-3-3  proteins
Historically, the ﬁrst reported targets of protein Ser/Thr kinases
were enzymes involved in central metabolic pathways [36], dis-
coveries which contributed to the understanding of hormonal
control of cellular metabolism. In fact, metabolic regulation by
Ser/Thr phosphorylation is crucial to cellular function. How-
ever, the impact of 14-3-3 proteins on regulation of metabolic
enzyme activities is still poorly understood in mammals. In a
large scale afﬁnity puriﬁcation study of 14-3-3 binding partners
from HeLa cell lysates, using yeast 14-3-3 (BMH1) as bait and
elution with the 14-3-3 binding peptide ARAApSAPA, MacKin-
tosh and colleagues identiﬁed several key enzymes in central
metabolism as potential binding partners of 14-3-3 [2]. These
included enzymes involved in glycolysis, pentose phosphate
pathway, fatty acid synthesis, nucleotide synthesis, methionine
metabolism, and reductive metabolism. Interestingly, in a similar
study using mammalian 14-3-3
 as bait, several of these metabolic
enzymes were conﬁrmed, including pyruvate kinase M (PK),
ATP-synthase (AS), glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), fatty acid synthase (FAS) and the bifunctional enzyme 6-
phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2) [1]
(Fig. 1). Many of these enzymes and additional proteins have
been found to interact with 14-3-3 in subsequent investigations
[7,37]. Interestingly, the heart isoform of PFK-2 was identi-
ﬁed as a 14-3-3 target upon phosphorylation by AKT but not
5′AMP-activated protein kinase (AMPK), locking the enzyme
in its glycolysis stimulating state in response to insulin [38]
(Fig. 1).
Together, these ﬁndings indicate that 14-3-3 proteins may
directly interact with and modify the functions of enzymes that
are of central importance in metabolic regulation. However, for
most of the protein targets that were identiﬁed in the above screen-
ing studies, the binding kinetics and biological implications of the
interactions are not yet fully elucidated. Instead, most of our knowl-
edge of 14-3-3 action on metabolic regulation comes from detailed
studies on a limited number of regulatory enzymes involved in
specialized biological pathways. The regulation of monoamine
biosynthesis by the aromatic amino acid hydroxylases is of partic-
ular importance both for historical reasons and because the details
of interactions have been studied in quantitative terms by many
different groups.
The  biosynthesis of catecholamine and serotonin neurotrans-
mitters and hormones is tightly regulated at the level of the
rate-limiting enzymes in these pathways (tyrosine hydroxylase
R. Kleppe et al. / Seminars in Cell & Developmental Biology 22 (2011) 713– 719 715
Fig. 1. Involvement of 14-3-3 proteins in regulation of cellular energy metabolism. The ﬁgure summarizes binding of 14-3-3 (blue) to important targets and their placement
in core metabolic pathways and regulatory signaling pathways. The metabolic pathways are illustrated with broad arrows or spirals (fatty acid synthesis or oxidation) and
only  selected intermediates and enzymes, which are reported as 14-3-3 binding partners, are shown. Interactions with metabolic enzymes that are reported in interactomics
studies are shown with dotted lines. Phosphorylation events are shown as (P) with arrows from the kinase involved, where stimulating phosphorylation (and 14-3-3 binding)
are  shown on white background and inhibitory phosphorylation on black. Metabolic intermediates are abbreviated Gluc (glucose), Gluc-6P (glucose-6-phosphate), Fruc-
6P  (fructose-6-phosphate), PEP (phosphoenolpyruvate), Pyr (pyruvate), AcCoA (acetyl coenzyme A), Glyc-3-P (glycerol-3-phosphate), Rib-5P (ribose-5-phosphate) and the
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[nzymes  CL (citrate lyase), ACC (acetyl-CoA carboxylase) and PKC (protein kinase C
TH) and tryptophan hydroxylase (TPH), respectively). Before any
ther functional roles of 14-3-3 proteins had been discovered, in a
eries of pioneering studies it was shown that activation of TH and
PH by phosphorylation was dependent on an additional protein
actor that could be separated from the hydroxylases [32]. Upon
ubsequent identiﬁcation of the activator protein as a mixture of
4-3-3 proteins [39], access to puriﬁed enzymes and speciﬁc anti-
odies, it has been shown that all seven human 14-3-3 isoforms,
s well as the proteins BMH1 and BMH2 bind to phosphorylated
H and TPH, albeit with different afﬁnities and binding speciﬁcities
40–43].other abbreviations we refer to the text and abbreviations section.
In rats and humans TH is encoded by a single gene that is subject
to alternative splicing, resulting in multiple isoforms with slightly
different N-terminal sequences, also affecting their phosphory-
lation and 14-3-3 binding sites [41,44]. The 14-3-3-dependent
TH  activation/stabilization requires the phosphorylation at Ser19
[41,44]. Phosphorylation at this position also increases the rate
of Ser40 phosphorylation by PKA, a modiﬁcation that releases the
feedback inhibition by catecholamines [44–47]. Binding to 14-3-3
preserves the stability of the highly active and polyphosphory-
lated TH, and it also appears to be important for the subcellular
enzyme localization and coordinated dopa/dopamine synthesis
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nd release (see below). TPH is encoded by two separate genes,
esulting in the homologous enzymes TPH1 and TPH2, with dif-
erent tissue distributions, regulatory properties and physiological
unctions [48]. As for TH, 14-3-3 binding to TPH1 and TPH2
onsolidates the enzyme activation that is induced by phospho-
ylation, protects the phosphoproteins against dephosphorylation,
nd increases their thermal stability [40,43]. Another example of
ne regulation of a metabolic pathway by regulation of enzyme
ctivity and stability through complex formation with 14-3-3 is
ound for melatonin synthesis in the pineal gland. Melatonin syn-
hesis constitutes the ﬁnal stage in this biosynthetic pathway from
ryptophan (serotonin → N-acetylserotonin → melatonin), where
rylalkylamine N-acetyltransferase (AANAT) is the penultimate
nzyme. Both the intrinsic circadian clock and light exposure regu-
ate AANAT at the transcriptional and translational level in concert
ith TPH and hydroxyindole-O-methyltransferase (HIOMT) that
perate in the preceeding and succeeding steps in the pathway.
ut ﬁne regulation of AANAT activity occurs through light-
ependent phosphorylation at two sites in the enzyme, i.e. Thr31
nd Ser205, that differently affect the afﬁnity of the enzyme for
4-3-3
 [49].
.  Regulation of metabolic processes by signaling pathways
 impact of 14-3-3
Cellular  functions, growth and proliferation are controlled by
ignaling pathways that sense the energy and nutrient status of
he cell. The AMPKs (AMPK1–3) are important cellular sensors of
he AMP:ATP ratio and are key regulators of energy consuming
nd energy producing pathways. These heterotrimeric (, , )
nzymes are activated by AMP  binding to their -subunit, making
he activation loop of the catalytic -subunit available for activation
y Thr172 phosphorylation by an upstream AMPK Kinase [50]. In
ost cells the tumor suppressor liver kinase B1 (LKB1/STK11) acts
s the master regulator, not only of AMPK, but also of other kinases
n the AMPK family, including salt-inducible kinase 1–3 (SIK1–3)
nd the MAP/microtubule-regulating kinase 1–4 (MARK1–4) [51]
Fig. 1).
Control of localization and activity of AMPKs by 14-3-3 proteins
as ﬁrst described for the MARKs (also called Partitioning defective
Par) 1a–d), which are involved in regulating cellular polarity [52]
Par-5 is also a 14-3-3 protein in Caenorhabditis elegans), but is also
eported for the SIKs [53]. In particular SIK2, but also MARK2 and
MPK play an important role in metabolic regulation through the
epression of the CREB coactivator, cAMP-regulated transcriptional
oactivator (CRTC) and thereby suppress hepatic gluconeogenesis
54]. Phosphorylation-dependent binding of 14-3-3 to CRTC with
esulting localization to the cytosol seems to be an important reg-
latory mechanism [55], suggesting that 14-3-3 proteins act to
onsolidate suppression of gluconeogenesis through SIK2 and CRTC
s well as insulin signaling (below) (Fig. 1).
There is considerable cross-talk between the AMPK pathway
nd other key energy regulatory pathways such as the Target of
apamycin (TOR) signaling complex 1 (TORC1) and insulin sig-
aling. The TORC1 plays a key role in adapting cellular growth
o nutrient availability [56]. The regulatory-associated protein of
OR (RAPTOR) containing complex stimulates ribosome biogenesis,
rotein translation through phosphorylation of S6 kinase 1 (S6K1)
nd eIF4E-binding protein 1 (4E-BP1) and inhibits autophagy by
hosphorylation of unc-51-like kinase 1 (ULK1) and autophagy
elated 13 (ATG13) [56,57] (Fig. 1). The mammalian TORC1
mTORC1) also depends on stimulatory input from the GTPase
HEB (Ras homologue enriched in brain), which receives inhibitory
nput from the GAP containing protein complex of Tuberous sclero-
is protein 1 and 2 (TSC1/Hamartin and TSC2/Tuberin) [56]. Muchpmental Biology 22 (2011) 713– 719
of  the modulation of mTORC1 is mediated through TSC1/2, such as
growth factor signaling, AMPK and hypoxia. Inhibitory phosphory-
lation of TSC1/2 by AKT and MAPKAPK2 facilitates binding of 14-3-3
[58,59], and a prevailing hypothesis of hypoxia-induced inhibition
of mTORC1 is by Rebb1 induction and sequestration of 14-3-3 away
from TSC2 [60] (Fig. 1).
AMPK  is reported to inhibit mTORC1 by activation of TSC1/2 and
by inhibition of RAPTOR by phosphorylation-induced binding of 14-
3-3 [61], both of which will stimulate autophagy. Recently, a direct
stimulatory path from AMPK to autophagy was  described through
phosphorylation of ULK1 [62], and complex formation between
ULK1, mTORC1 and AMPK has been found to coincide with RAPTOR
phosphorylation and binding of 14-3-3 [63] (Fig. 1). Judging from
the 14-3-3:RAPTOR interaction, 14-3-3 seems to be on both sides
of the equation for autophagy. Interestingly, 14-3-3
 has recently
been reported to inhibit autophagy through inhibition of the class
III phosphatidylinositol-3-kinase (PI3K-III) [64], which is necessary
for autophagosome vesicle nucleation. 14-3-3
 is also an inter-
action partner of BH3-only family members of the Bcl-2 protein
family, such as Bcl-2 antagonist of death (BAD) and BCL-2 inter-
acting mediator of cell death (BIM), as well as the pore forming
Bcl-2 associated X protein (BAX) [65–67]. Hence, increased 14-3-
3
 should shift the balance of BCL-2 proteins towards survival, but
also release more BCL-2/BCL-XL for binding to BECLIN-1 (ATG6) and
thereby suppress autophagy of mitochondria and ER [68] (Fig. 1).
Downstream of insulin and growth factor stimulation, AKT is
activated by PDK1 and the RICTOR (rapamycin-insensitive com-
panion of TOR) containing TOR complex 2 (TORC2), leading to AKT
and ERK mediated inhibition of TSC1/TSC2 and stimulation of the
mTORC1 pathway. A second path of insulin to mTORC1 activation
is mediated by AKT phosphorylation and inhibition of the TORC1
inhibitory protein Proline-rich AKT substrate 40 (PRAS40), which
associates with RAPTOR [69]. Binding of 14-3-3 to phosphorylated
PRAS40 is important to release its suppression of TORC1 [70], but
the exact mechanism is still not settled. The presence of PRAS40
seems to be important for TORC1 activity, whereas TORC1 mediated
phosphorylation of PRAS40 is implicated in the release of PRAS40
suppression [71] (Fig. 1).
A major effect of insulin in skeletal muscle and adipose tissue
is increased uptake of glucose from the blood. This is mediated
by increased translocation of glucose transporter 4 (GLUT4) to the
plasma membrane by Rab-mediated vesicular transport. In resting
cells this transport is inhibited by Rab-GAPs such as Akt Substrate
160 (AS160/TBC1D4) and TBC1D1, which are both phosphory-
lated by AKT in response to insulin [72,73]. AKT phosphorylation
facilitates binding of 14-3-3 and cytosolic translocation of AS160
and TBC1D1 with subsequent release of its suppressive activity
[74] (Fig. 1). Interestingly, a knock-in mouse of AS160 with a
disrupted phosphorylation- and binding site of 14-3-3 showed
decreased insulin-stimulated GLUT4-translocation in muscle and
insulin insensitivity with respect to glucose tolerance [75]. Paral-
lel to increased glucose uptake, insulin stimulates glucose storage
as glycogen in liver and muscle by AKT-mediated inactivation of
glycogen synthase kinase 3 (GSK3), which suppresses glycogen syn-
thesis. The -isoform of GSK3 is a known binding partner for 14-3-3
upon Ser9 phosphorylation, but this interaction has received more
attention for its role in GSK3 mediated phosphorylation of Tau
[76] (Fig. 1). The relative roles of GSK3 and  in regulation of glyco-
gen synthesis in different tissues are yet not resolved. However, a
recently discovered link between GSK3 and inactivation of RICTOR
of TORC2 [77], important for insulin induced uptake of glucose in
muscle [78], suggests a possible role of 14-3-3 in GSK3-mediated
insulin resistance.
The  apparent involvement of 14-3-3 proteins in the regulation
of energy metabolism, mTOR signaling and autophagy in addition
to their well-known roles in apoptotic and cell-cycle signaling,
evelopmental Biology 22 (2011) 713– 719 717
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Fig. 2. The consolidating action of 14-3-3 on target phosphorylation. Panel (A)
shows part of a signaling pathway where a protein kinase is activated (modeled by
fractional activation) by a signal input (e.g. external signal or internal second mes-
senger) according to a sigmoid activation function, where S is the signal input, S0.5 is
the signal input that gives half fractional activation of the kinase (here 10 nM)  and h
is the Hill coefﬁcient of the kinase signal response (here 1.5). Panel (B) shows a down-
stream target protein (TP) ([TP] = 0.5 M)  of the activated kinase (Kinase*), which is
dephosphorylated by a protein phosphatase (PP) and which may  interact with 14-
3-3 proteins (set to 5 M)  in phosphorylation dependent manner. The steady state
amount of total TP phosphorylation in response to the signal input is calculated for
TP with different afﬁnities to 14-3-3 (Kd = 0.5, 50, 500 and ∞ nM). Thus, from a maxi-
mal TP phosphorylation response of 9% in the absence of 14-3-3 binding, decreasing
the  Kd (500 nM,  ©; 50 nM,  ; 0.5 nM,  ) both ampliﬁes (5.8-, 10- and 11-fold, respec-
tively)  and sensitize (about 2-, 5- and 10-fold, respectively) the TP phosphorylation
response  to S. The modeling was performed in Copasi (v4.5) [90] using rate of
phosphorylation VK∗ = kphos(Sh/(Sh0.5 + Sh)) · [Kinasetot] · [TP], where [Kinasetot] = 1,−1 −1 −1 −1R. Kleppe et al. / Seminars in Cell & D
lso makes them interesting for understanding carcinogenesis (see
eview by Yaffe et al. in this issue) [93].
. Effector mechanisms of 14-3-3 proteins
.1. Localization to membranes
The  regulatory functions of 14-3-3 proteins extend beyond acti-
ation, inhibition, stabilization or orientation of its partners, as
4-3-3 also modulate the speciﬁc subcellular localization of their
argos [79]. It is well established that 14-3-3 sequesters proteins
n the cytoplasm, inhibiting nuclear or mitochondrial localization
f speciﬁc partners, though less is known about isoform-speciﬁc
ifferences [80,81]. However, there is also increasing evidence on
he role of 14-3-3 in the transfer of binding partners to membranes
82,83].
In addition to the unique role of biological membranes in cell
ompartmentalization, membranes allow the formation and func-
ion of specialized, multi-enzyme units. Several of the protein
omponents of these units interact with membranes peripheral-
nd reversibly and this interaction can be mediated in several ways,
ncluding phosphorylation and modulations of charge–charge
elationships [84]. The lowered dielectric constant and lower
H in the vicinity of a biological negatively charged mem-
rane are often the driving forces for peripheral interactions.
e have recently shown that 14-3-3 interacts reversibly with
egatively charged membranes [84,85]. The membrane afﬁnity
f 14-3-3 is high for phospholipid compositions that mimic
hat of synaptic vesicles, with a high content of 1-stearoyl-2-
ocosahexaenoyl-phosphatidylserine (SDPS) and increases when
 Ser19-phosphorylated TH-derived peptide is bound to 14-3-3
84], suggesting a role of this 14-3-3 isoform in membrane local-
zation of TH. Though mainly cytoplasmatic, a fraction of TH is also
ound as membrane-bound both in brain, notably at nerve end-
ngs and synaptic vesicles, and in catecholamine secretory granules
n adrenal medulla [86]. The signiﬁcance of the binding of TH to
embranes is not clear but it is assumed to have a role in the coordi-
ation of dopamine synthesis and release since dopa decarboxylase
lso forms functional complexes with TH at membranes [87].
.2.  Effects on target protein phosphorylation
By speciﬁcally associating with the phosphorylated state of the
arget proteins, the 14-3-3 proteins will shield against dephos-
horylation. The efﬁciency of the protection will depend on the
issociation constant (Kd) of the complex and the effective con-
entrations of the binding partners. For 14-3-3 target protein (TP)
ssociation, Kd-values in the sub-nanomolar to micromolar range
re generally reported [41,80,88]. The inﬂuence of 14-3-3 binding
n the steady state level of target phophorylation can therefore be
redicted, as exempliﬁed by the simple case of monovalent phos-
horylation and TP binding to 14-3-3 (Fig. 2A and B). In this model,
ven for moderate binding afﬁnities (Kd = 0.5 M),  a ∼6-fold ampli-
cation of the signal (phospho-TP) response is observed, and for
igher afﬁnities signiﬁcant sensitization is predicted in addition to
rominent signal ampliﬁcation.
Binding  of dimeric 14-3-3 covers a considerable surface area of
he TP and this may  affect its localization, oligomerization/complex
ormation, or further protein modiﬁcations. 14-3-3 Binding can
e considered efﬁcient and dynamic means of inducing secondary
ffects of phosphorylation on protein function, as compared to
ther proteins that obtain similar responses through conforma-
ional changes. The 14-3-3 proteins are able to simultaneously bind
wo phospho-target sites, either to obtain high afﬁnity interaction
coincidence detector) or to elicit structural effects upon bindingkphos = 0.5 M s and rate of dephosphorylation VPP = 5 M s · [PPtot] · [pTP]
([PPtot] = 1), whereas the association with 14-3-3, ka was  set to 0.5 M−1 s−1 and Kd
to fulﬁll the Kd [39].
(gatekeeper phosphorylation, molecular anvil [89]). These issues
are discussed in [10], and the coincidence detector property of 14-
3-3 can easily be visualized from Fig. 2B, where two  versus one
phosphorylation events dramatically increase the binding afﬁnity,
resulting in both signal ampliﬁcation and sensitization.
5. Concluding remarks
The  regulation of cellular metabolism by 14-3-3 proteins is an
area ripe for further investigations. The 14-3-3 interactomic studies
suggest that key metabolic enzymes are well represented among
14-3-3’s cellular binding partners. The current understanding of
how 14-3-3 proteins regulate their targets is likely to be valid
for other metabolic enzymes as well. This will also provide addi-
tional mechanistic insight into how such enzymes are regulated by
phosphorylation. Potential avenues for future research include how
14-3-3 proteins control enzyme activities and turnover, modulate
single- or multiple phosphorylation events, and regulate metabolic
activities at different cellular locations.
The presence of many alternative binding partners for 14-3-3s
in the cell poses several important and unresolved issues related to
our understanding of their ability to modulate cellular processes.
How do different 14-3-3 ligands compete for complex formation?
The total cellular level of 14-3-3 proteins is quite high, but the many
interaction partners means that only a proportion of the 14-3-3
7 evelo
p
t
r
c
b
p
l
t
3
b
c
s
s
t
b
r
t
A
T
S
R
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[18 R. Kleppe et al. / Seminars in Cell & D
roteins will be free to engage partners in the cell. Unfortunately,
he concentration of free 14-3-3 for the various 14-3-3 isoforms
emains unknown.
The  14-3-3 proteins are certainly involved in many cellular pro-
esses that already are in focus for pharmacological intervention,
ut their broad involvement makes one wonder whether 14-3-3
roteins are realistic as targets for drugs either inhibiting or stabi-
izing their interactions in general. A feasible approach may  be to
arget the unique protein–protein interface present for each 14-3-
:target protein complex. It remains to be seen if this speciﬁcity can
e achieved at the organism level (see reviews by Fu et al. for dis-
ussion) [12,91]. Recently, the fungal phytotoxin fusicoccin, which
tabilizes the interaction between plant 14-3-3 and H+-ATPase, was
hown to promote platelet aggregation, presumably via stabiliza-
ion of the 14-3-3-glycoprotein Ib complex [92]. Clearly, more
asic knowledge and improved models and drug candidates are
equired to exploit the potential of the 14-3-3-proteins as drug
argets.
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